Table 2.
Feature | VISTA in venous tumor thrombus | VISTA in primary tumor | ||||
---|---|---|---|---|---|---|
Negative | Positive | p-value | Negative | Positive | p-value | |
Sex | ||||||
Female | 10 (28) | 26 (72) | 0.034 | 20 (54) | 17 (46) | 0.959 |
Male | 23 (51) | 22 (49) | 23 (53) | 20 (47) | ||
Tumor size | ||||||
< 10 cm | 21 (43) | 28 (57) | 0.631 | 21 (44) | 27 (56) | 0.028 |
> 10 cm | 12 (37) | 20 (63) | 22 (69) | 10 (31) | ||
Nodal metastases | ||||||
No | 28 (42) | 38 (58) | 0.518 | 33 (51) | 32 (49) | 0.265 |
Yes | 5 (33) | 10 (67) | 10 (67) | 5 (33) | ||
Distant metastases | ||||||
No | 28 (48) | 30 (52) | 0.028 | 33 (58) | 24 (42) | 0.241 |
Yes | 5 (22) | 18 (78) | 13 (57) | 10 (43) | ||
Grade | ||||||
2–3 | 14 (52) | 13 (48) | 0.150 | 15 (56) | 12 (44) | 0.817 |
4 | 19 (35) | 35 (65) | 28 (53) | 25 (47) | ||
Tumor necrosis | ||||||
No | 23 (53) | 20 (47) | 0.013 | 24 (57) | 18 (43) | 0.522 |
Yes | 10 (26) | 28 (74) | 19 (50) | 19 (50) |
p-values ≤ 0.05 were considered statistically significant (in bold)
p-values were calculated with the chi-square test
VISTA V-domain Ig suppressor of T cell activation. P values calculated with chi-square test